Feb 25, 2026 01:50PM

Feb 25, 2026 01:44PM

Feb 25, 2026 10:02AM

Feb 24, 2026 09:38AM

Feb 24, 2026 08:23AM

Feb 23, 2026 12:32PM

Feb 23, 2026 09:31AM Raymond James on Legend Biotech Corp. (LEGN): 'Arcellx Takeout Indicates Legend is Hugely Undervalued'

Feb 23, 2026 06:01AM

Feb 23, 2026 06:01AM

Feb 17, 2026 08:30AM

Feb 10, 2026 04:01PM

Dec 24, 2025 07:00AM

Dec 22, 2025 08:02AM

Dec 22, 2025 08:00AM Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes

Dec 15, 2025 08:30AM

Dec 15, 2025 08:30AM

Dec 12, 2025 10:31AM

Nov 18, 2025 05:09AM

Nov 18, 2025 05:00AM

Nov 13, 2025 08:30AM

Nov 13, 2025 08:30AM Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV-1 Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-1 Trial

Oct 31, 2025 08:00AM

Oct 30, 2025 04:02PM

Oct 19, 2025 08:30AM

Oct 15, 2025 04:08AM

Oct 15, 2025 03:30AM

Sep 4, 2025 02:15PM

Sep 4, 2025 02:15PM Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries

Aug 26, 2025 03:00AM

Aug 21, 2025 08:30AM

Aug 21, 2025 08:30AM

Aug 7, 2025 04:02PM

Jul 25, 2025 05:58AM

Jul 25, 2025 03:00AM

Jul 14, 2025 09:31AM Gilead presents data on twice-yearly HIV prevention drug at IAS 2025

Jul 14, 2025 09:30AM

Jul 9, 2025 08:00AM

Jun 18, 2025 02:50PM

Jun 18, 2025 02:49PM

Apr 24, 2025 04:02PM

Mar 18, 2025 04:35PM

Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma

Mar 11, 2025 01:38PM

Mar 11, 2025 01:37PM

Mar 4, 2025 08:23AM

Feb 25, 2025 10:59AM

Feb 24, 2025 08:30AM

Feb 18, 2025 08:30AM

Feb 18, 2025 08:30AM U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review

Feb 11, 2025 04:08PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All